You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 3, March 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Abnormal Serum Transaminase Levels in Patients With Hemophilia A

Andrew I. Cederbaum, MD; Philip M. Blatt, MD; Peter H. Levine, MD

Arch Intern Med. 1982;142(3):481-484.


Abstract

In a cooperative study of 1,332 hemophiliacs, the results of a variety of liver function tests were correlated with the intensity and type of exposure to plasma products. After three sets of measurements at six-month intervals, 72% of patients had at least one abnormal transaminase value and 21.1% and 23.6% of patients had persistently elevated SGOT and SGPT levels, respectively, on all three measurements. Patients who had received no factor VIII during the previous year had fewer abnormalities than treated patients. Only those treated patients who received less than 50 units of factor VIII per kilogram per six months had fewer transaminase abnormalities if they used cryoprecipitate than if they used concentrate, but these patient groups are not strictly comparable, in that the cryoprecipitate-treated group contained a higher proportion of patients with mild hemophilia than did the concentrate-treated group.

(Arch Intern Med 1982;142:481-484)



Author Affiliations

From the Department of Medicine, The Memorial Hospital and the University of Massachusetts Medical School, Worcester (Drs Cederbaum and Levine); and the Department of Medicine, University of North Carolina Medical Center, Chapel Hill (Dr Blatt).


Footnotes

Accepted for publication March 9, 1981.

Reprint requests to The Memorial Hospital, 119 Belmont St, Worcester, MA 01605 (Dr Cederbaum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High Prevalence of Antibody to Hepatitis C Virus in Multitransfused Hemophiliacs with Normal Transaminase Levels
Rumi et al.
ANN INTERN MED 1990;112:379-380.
ABSTRACT  

The Acquired Immunodeficiency Syndrome in Persons with Hemophilia
LEVINE
ANN INTERN MED 1985;103:723-726.
ABSTRACT  

Hemophilia, Hepatitis, and the Acquired Immunodeficiency Syndrome
WHITE and LESESNE
ANN INTERN MED 1983;98:403-404.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.